APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Reference Substance (CMRS)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chinese Medicine Reference Substance (CMRS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchChinese Medicine Reference Substance (CMRS) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Reference Substance (CMRS) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Reference Substance (CMRS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Reference Substance (CMRS) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Reference Substance (CMRS) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chinese Medicine Reference Substance (CMRS) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chinese Medicine Reference Substance (CMRS) include Baoji Herbest Bio-Tech, ChemFaces, ChromaDex, Diagnocine, PhytoLab, Derick, Desite, GeLiPuBio and Chengdu Must Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Medicine Reference Substance (CMRS) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Reference Substance (CMRS) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Reference Substance (CMRS) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Medicine Reference Substance (CMRS) market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Medicine Reference Substance (CMRS) Segment by Company

Baoji Herbest Bio-Tech

ChemFaces

ChromaDex

Diagnocine

PhytoLab

Derick

Desite

GeLiPuBio

Chengdu Must Biotechnology

Purechemland

Nature Standard

RENI Pharmaceutical Technology

Chinese Medicine Reference Substance (CMRS) Segment by Type

Plant-Derived Reference Substances

Mineral-Derived Reference Substances

Chemically Synthesized Reference Substances

Animal-Derived Reference Substances

Chinese Medicine Reference Substance (CMRS) Segment by Application

Pharmaceutical Identification

Pharmaceutical Development

Chinese Medicine Reference Substance (CMRS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Reference Substance (CMRS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Reference Substance (CMRS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Reference Substance (CMRS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Medicine Reference Substance (CMRS) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chinese Medicine Reference Substance (CMRS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chinese Medicine Reference Substance (CMRS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chinese Medicine Reference Substance (CMRS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Reference Substance (CMRS) Industry Trends Table 2. Chinese Medicine Reference Substance (CMRS) Industry Drivers Table 3. Chinese Medicine Reference Substance (CMRS) Industry Opportunities and Challenges Table 4. Chinese Medicine Reference Substance (CMRS) Industry Restraints Table 5. Global Chinese Medicine Reference Substance (CMRS) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chinese Medicine Reference Substance (CMRS) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Manufacturers Table 9. Global Chinese Medicine Reference Substance (CMRS) Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Chinese Medicine Reference Substance (CMRS) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chinese Medicine Reference Substance (CMRS) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chinese Medicine Reference Substance (CMRS) Manufacturers, Product Type & Application Table 13. Global Chinese Medicine Reference Substance (CMRS) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Medicine Reference Substance (CMRS) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plant-Derived Reference Substances Table 17. Major Manufacturers of Mineral-Derived Reference Substances Table 18. Major Manufacturers of Chemically Synthesized Reference Substances Table 19. Major Manufacturers of Animal-Derived Reference Substances Table 20. Global Chinese Medicine Reference Substance (CMRS) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021-2026) & (k units) Table 22. Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2027-2032) & (k units) Table 23. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2021-2026) Table 24. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2027-2032) Table 25. Global Chinese Medicine Reference Substance (CMRS) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2021-2026) & (k units) Table 27. Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2027-2032) & (k units) Table 28. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2021-2026) Table 29. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceutical Identification Table 31. Major Manufacturers of Pharmaceutical Development Table 32. Global Chinese Medicine Reference Substance (CMRS) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021-2026) & (k units) Table 34. Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2027-2032) & (k units) Table 35. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2021-2026) Table 36. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2027-2032) Table 37. Global Chinese Medicine Reference Substance (CMRS) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2021-2026) & (k units) Table 39. Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2027-2032) & (k units) Table 40. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2021-2026) Table 41. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2027-2032) Table 42. Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2021-2026) & (k units) Table 44. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region (2021-2026) Table 45. Global Chinese Medicine Reference Substance (CMRS) Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Chinese Medicine Reference Substance (CMRS) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 49. North America Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 50. Europe Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 52. Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 59. Global Chinese Medicine Reference Substance (CMRS) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Chinese Medicine Reference Substance (CMRS) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Chinese Medicine Reference Substance (CMRS) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Region (2021-2026) Table 63. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Region (2027-2032) Table 64. Baoji Herbest Bio-Tech Company Information Table 65. Baoji Herbest Bio-Tech Business Overview Table 66. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 68. Baoji Herbest Bio-Tech Recent Development Table 69. ChemFaces Company Information Table 70. ChemFaces Business Overview Table 71. ChemFaces Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 73. ChemFaces Recent Development Table 74. ChromaDex Company Information Table 75. ChromaDex Business Overview Table 76. ChromaDex Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 78. ChromaDex Recent Development Table 79. Diagnocine Company Information Table 80. Diagnocine Business Overview Table 81. Diagnocine Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 83. Diagnocine Recent Development Table 84. PhytoLab Company Information Table 85. PhytoLab Business Overview Table 86. PhytoLab Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 88. PhytoLab Recent Development Table 89. Derick Company Information Table 90. Derick Business Overview Table 91. Derick Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Derick Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 93. Derick Recent Development Table 94. Desite Company Information Table 95. Desite Business Overview Table 96. Desite Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Desite Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 98. Desite Recent Development Table 99. GeLiPuBio Company Information Table 100. GeLiPuBio Business Overview Table 101. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 103. GeLiPuBio Recent Development Table 104. Chengdu Must Biotechnology Company Information Table 105. Chengdu Must Biotechnology Business Overview Table 106. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 108. Chengdu Must Biotechnology Recent Development Table 109. Purechemland Company Information Table 110. Purechemland Business Overview Table 111. Purechemland Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 113. Purechemland Recent Development Table 114. Nature Standard Company Information Table 115. Nature Standard Business Overview Table 116. Nature Standard Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 118. Nature Standard Recent Development Table 119. RENI Pharmaceutical Technology Company Information Table 120. RENI Pharmaceutical Technology Business Overview Table 121. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 123. RENI Pharmaceutical Technology Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Chinese Medicine Reference Substance (CMRS) Distributors List Table 127. Chinese Medicine Reference Substance (CMRS) Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Chinese Medicine Reference Substance (CMRS) Product Image Figure 2. Global Chinese Medicine Reference Substance (CMRS) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Reference Substance (CMRS) Market Size (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Reference Substance (CMRS) Sales (2021-2032) & (k units) Figure 5. Global Chinese Medicine Reference Substance (CMRS) Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chinese Medicine Reference Substance (CMRS) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plant-Derived Reference Substances Image Figure 9. Mineral-Derived Reference Substances Image Figure 10. Chemically Synthesized Reference Substances Image Figure 11. Animal-Derived Reference Substances Image Figure 12. Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2021-2032) Figure 15. Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceutical Identification Image Figure 19. Pharmaceutical Development Image Figure 20. Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2021-2032) Figure 23. Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2021-2032) Figure 26. North America Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 28. U.S. Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 33. Germany Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 40. China Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 48. Brazil Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Chinese Medicine Reference Substance (CMRS) Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Chinese Medicine Reference Substance (CMRS) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032) & (US$ Million) Figure 59. North America Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Chinese Medicine Reference Substance (CMRS) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Chinese Medicine Reference Substance (CMRS) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Plant-Derived Reference Substances
  • Mineral-Derived Reference Substances
  • Chemically Synthesized Reference Substances
  • Animal-Derived Reference Substances
Applications
  • Pharmaceutical Identification
  • Pharmaceutical Development
Companies covered
  • Baoji Herbest Bio-Tech
  • ChemFaces
  • ChromaDex
  • Diagnocine
  • PhytoLab
  • Derick
  • Desite
  • GeLiPuBio
  • Chengdu Must Biotechnology
  • Purechemland
  • Nature Standard
  • RENI Pharmaceutical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chinese Medicine Reference Substance (CMRS) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chinese Medicine Reference Substance (CMRS) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chinese Medicine Reference Substance (CMRS) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chinese Medicine Reference Substance (CMRS) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chinese Medicine Reference Substance (CMRS) Market Dynamics
  1. 2.1 Chinese Medicine Reference Substance (CMRS) Industry Trends
  2. 2.2 Chinese Medicine Reference Substance (CMRS) Industry Drivers
  3. 2.3 Chinese Medicine Reference Substance (CMRS) Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Reference Substance (CMRS) Industry Restraints
3 Chinese Medicine Reference Substance (CMRS) Market by Manufacturers
  1. 3.1 Global Chinese Medicine Reference Substance (CMRS) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chinese Medicine Reference Substance (CMRS) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chinese Medicine Reference Substance (CMRS) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chinese Medicine Reference Substance (CMRS) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chinese Medicine Reference Substance (CMRS) Manufacturers, Product Type & Application
  7. 3.7 Global Chinese Medicine Reference Substance (CMRS) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chinese Medicine Reference Substance (CMRS) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chinese Medicine Reference Substance (CMRS) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chinese Medicine Reference Substance (CMRS) Tier 1, Tier 2, and Tier 3
4 Chinese Medicine Reference Substance (CMRS) Market by Type
  1. 4.1 Chinese Medicine Reference Substance (CMRS) Type Introduction
  2. 4.1.1 Plant-Derived Reference Substances
  3. 4.1.2 Mineral-Derived Reference Substances
  4. 4.1.3 Chemically Synthesized Reference Substances
  5. 4.1.4 Animal-Derived Reference Substances
  6. 4.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Type
  7. 4.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021-2032)
  9. 4.2.3 Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2021-2032)
  10. 4.3 Global Chinese Medicine Reference Substance (CMRS) Revenue by Type
  11. 4.3.1 Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2021-2032)
  13. 4.3.3 Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2021-2032)
5 Chinese Medicine Reference Substance (CMRS) Market by Application
  1. 5.1 Chinese Medicine Reference Substance (CMRS) Application Introduction
  2. 5.1.1 Pharmaceutical Identification
  3. 5.1.2 Pharmaceutical Development
  4. 5.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Application
  5. 5.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021-2032)
  7. 5.2.3 Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Chinese Medicine Reference Substance (CMRS) Revenue by Application
  9. 5.3.1 Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2021-2032)
  11. 5.3.3 Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2021-2032)
6 Global Chinese Medicine Reference Substance (CMRS) Sales by Region
  1. 6.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2021-2026)
  4. 6.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region
  1. 7.1 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region
  2. 7.1.1 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region (2021-2026)
  4. 7.1.3 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region (2027-2032)
  5. 7.1.4 Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032)
  8. 7.2.2 North America Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032)
  11. 7.3.2 Europe Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Baoji Herbest Bio-Tech
  2. 8.1.1 Baoji Herbest Bio-Tech Company Information
  3. 8.1.2 Baoji Herbest Bio-Tech Business Overview
  4. 8.1.3 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolio
  6. 8.1.5 Baoji Herbest Bio-Tech Recent Developments
  7. 8.2 ChemFaces
  8. 8.2.1 ChemFaces Company Information
  9. 8.2.2 ChemFaces Business Overview
  10. 8.2.3 ChemFaces Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolio
  12. 8.2.5 ChemFaces Recent Developments
  13. 8.3 ChromaDex
  14. 8.3.1 ChromaDex Company Information
  15. 8.3.2 ChromaDex Business Overview
  16. 8.3.3 ChromaDex Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolio
  18. 8.3.5 ChromaDex Recent Developments
  19. 8.4 Diagnocine
  20. 8.4.1 Diagnocine Company Information
  21. 8.4.2 Diagnocine Business Overview
  22. 8.4.3 Diagnocine Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolio
  24. 8.4.5 Diagnocine Recent Developments
  25. 8.5 PhytoLab
  26. 8.5.1 PhytoLab Company Information
  27. 8.5.2 PhytoLab Business Overview
  28. 8.5.3 PhytoLab Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolio
  30. 8.5.5 PhytoLab Recent Developments
  31. 8.6 Derick
  32. 8.6.1 Derick Company Information
  33. 8.6.2 Derick Business Overview
  34. 8.6.3 Derick Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Derick Chinese Medicine Reference Substance (CMRS) Product Portfolio
  36. 8.6.5 Derick Recent Developments
  37. 8.7 Desite
  38. 8.7.1 Desite Company Information
  39. 8.7.2 Desite Business Overview
  40. 8.7.3 Desite Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Desite Chinese Medicine Reference Substance (CMRS) Product Portfolio
  42. 8.7.5 Desite Recent Developments
  43. 8.8 GeLiPuBio
  44. 8.8.1 GeLiPuBio Company Information
  45. 8.8.2 GeLiPuBio Business Overview
  46. 8.8.3 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolio
  48. 8.8.5 GeLiPuBio Recent Developments
  49. 8.9 Chengdu Must Biotechnology
  50. 8.9.1 Chengdu Must Biotechnology Company Information
  51. 8.9.2 Chengdu Must Biotechnology Business Overview
  52. 8.9.3 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolio
  54. 8.9.5 Chengdu Must Biotechnology Recent Developments
  55. 8.10 Purechemland
  56. 8.10.1 Purechemland Company Information
  57. 8.10.2 Purechemland Business Overview
  58. 8.10.3 Purechemland Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolio
  60. 8.10.5 Purechemland Recent Developments
  61. 8.11 Nature Standard
  62. 8.11.1 Nature Standard Company Information
  63. 8.11.2 Nature Standard Business Overview
  64. 8.11.3 Nature Standard Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolio
  66. 8.11.5 Nature Standard Recent Developments
  67. 8.12 RENI Pharmaceutical Technology
  68. 8.12.1 RENI Pharmaceutical Technology Company Information
  69. 8.12.2 RENI Pharmaceutical Technology Business Overview
  70. 8.12.3 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolio
  72. 8.12.5 RENI Pharmaceutical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Medicine Reference Substance (CMRS) Value Chain Analysis
  2. 9.1.1 Chinese Medicine Reference Substance (CMRS) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Medicine Reference Substance (CMRS) Production Mode & Process
  6. 9.2 Chinese Medicine Reference Substance (CMRS) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Medicine Reference Substance (CMRS) Distributors
  9. 9.2.3 Chinese Medicine Reference Substance (CMRS) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst